Advertisement
YOU ARE HERE: LAT HomeCollectionsIcos Corp
IN THE NEWS

Icos Corp

FEATURED ARTICLES
BUSINESS
January 11, 2005
Microsoft Corp. Chairman Bill Gates will resign Feb. 9 from the board of drug developer ICOS Corp. to focus his attention on his board seat at Warren Buffett's Berkshire Hathaway Inc., according to a regulatory filing Monday. ICOS co-developed erectile dysfunction treatment Cialis.
ARTICLES BY DATE
BUSINESS
December 8, 2006 | From Bloomberg News
Eli Lilly & Co. projected a 2007 earnings rise that trailed analysts' estimates because the planned purchase of Icos Corp., maker of the impotence pill Cialis, would reduce profit more than some analysts expected. Net income next year will be $3.25 to $3.35 a share, said the Indianapolis-based maker of Zyprexa, the world's top-selling schizophrenia medicine, at an investor meeting in New York. Its shares fell 87 cents, or 1.6%, to $53.99.
Advertisement
BUSINESS
October 22, 1991 | BARRY STAVRO, TIMES STAFF WRITER
George Rathmann spent the 1980s nurturing a tiny Thousand Oaks company named Amgen Inc. from a vague idea into the most successful biotechnology company yet developed. His goal for the 1990s was simpler: retire. So why is Rathmann, now 63, working as hard as ever at the helm of another infant biotechnology company called Icos Corp. in Bothell, Wash., and trying to duplicate his triumph at Amgen? "There's an irrational element in this," Rathmann conceded about his retirement detour.
BUSINESS
January 11, 2005
Microsoft Corp. Chairman Bill Gates will resign Feb. 9 from the board of drug developer ICOS Corp. to focus his attention on his board seat at Warren Buffett's Berkshire Hathaway Inc., according to a regulatory filing Monday. ICOS co-developed erectile dysfunction treatment Cialis.
BUSINESS
December 8, 2006 | From Bloomberg News
Eli Lilly & Co. projected a 2007 earnings rise that trailed analysts' estimates because the planned purchase of Icos Corp., maker of the impotence pill Cialis, would reduce profit more than some analysts expected. Net income next year will be $3.25 to $3.35 a share, said the Indianapolis-based maker of Zyprexa, the world's top-selling schizophrenia medicine, at an investor meeting in New York. Its shares fell 87 cents, or 1.6%, to $53.99.
BUSINESS
December 13, 1994 | Jack Searles
George Rathmann, the founder of Amgen Inc., the Thousand Oaks biotechnology concern, has increased his ownership in another biotech firm, Bothell, Wash.-based Icos Corp. Rathmann, who is Icos' chairman, along with Microsoft Corp. founder William Gates bought about half the Icos shares available in a special offering last month. The two executives, who are among Icos' largest shareholders, acted independently. Rathmann raised his stake to about 7.8% from 6.5%.
BUSINESS
May 27, 2002 | Associated Press
A yet-to-be-approved impotence drug developed by Eli Lilly & Co. and Icos Corp. appears to be longer-lasting than Viagra, the companies said, citing a study to be released at a medical conference today. Patients in the study reported success in achieving erections from 24 hours to as long as 36 hours after taking a 20-milligram pill of Cialis (pronounced see-ALL-iss), Lilly and Icos said. The study did not compare Cialis' effects directly with those of Viagra, the $1.
BUSINESS
November 9, 2000 | From Bloomberg News
Pfizer Inc. on Wednesday lost a patent ruling that could allow competition in Britain for its Viagra impotence drug from a venture backed by Microsoft Corp. Chairman Bill Gates. An English High Court justice ruled in favor of a patent challenge by Icos Corp. and Eli Lilly & Co., which set up a joint venture for an experimental impotence drug. Gates is Icos' largest shareholder.
BUSINESS
June 29, 2001 | DENISE GELLENE, TIMES STAFF WRITER
A small biotechnology firm whose investors include a co-founder of Amgen Inc. and Microsoft's Bill Gates sought government approval Thursday of an impotence drug that would challenge the blockbuster Viagra. Icos Corp., based in Bothell, Wash., said its drug Cialis lasts up to six times longer than Viagra, which wears off after four hours. Icos spokeswoman Lacy Fitzpatrick said the longer duration of Cialis means men needn't "watch the clock" after taking the medication.
BUSINESS
May 30, 1998 | From Times Wire Services
Shares of Icos Corp., a biotechnology company with no products on the market, soared 30% on Friday on enthusiasm about its impotence drug, which may rival Pfizer Inc.'s blockbuster Viagra. Icos, whose biggest shareholder is Microsoft Corp. Chairman Bill Gates, with a 13% stake, is only starting the second of three phases of testing needed to get regulatory approval for its impotence drug.
BUSINESS
May 27, 2002 | Associated Press
A yet-to-be-approved impotence drug developed by Eli Lilly & Co. and Icos Corp. appears to be longer-lasting than Viagra, the companies said, citing a study to be released at a medical conference today. Patients in the study reported success in achieving erections from 24 hours to as long as 36 hours after taking a 20-milligram pill of Cialis (pronounced see-ALL-iss), Lilly and Icos said. The study did not compare Cialis' effects directly with those of Viagra, the $1.
BUSINESS
June 29, 2001 | DENISE GELLENE, TIMES STAFF WRITER
A small biotechnology firm whose investors include a co-founder of Amgen Inc. and Microsoft's Bill Gates sought government approval Thursday of an impotence drug that would challenge the blockbuster Viagra. Icos Corp., based in Bothell, Wash., said its drug Cialis lasts up to six times longer than Viagra, which wears off after four hours. Icos spokeswoman Lacy Fitzpatrick said the longer duration of Cialis means men needn't "watch the clock" after taking the medication.
BUSINESS
November 9, 2000 | From Bloomberg News
Pfizer Inc. on Wednesday lost a patent ruling that could allow competition in Britain for its Viagra impotence drug from a venture backed by Microsoft Corp. Chairman Bill Gates. An English High Court justice ruled in favor of a patent challenge by Icos Corp. and Eli Lilly & Co., which set up a joint venture for an experimental impotence drug. Gates is Icos' largest shareholder.
BUSINESS
May 30, 1998 | From Times Wire Services
Shares of Icos Corp., a biotechnology company with no products on the market, soared 30% on Friday on enthusiasm about its impotence drug, which may rival Pfizer Inc.'s blockbuster Viagra. Icos, whose biggest shareholder is Microsoft Corp. Chairman Bill Gates, with a 13% stake, is only starting the second of three phases of testing needed to get regulatory approval for its impotence drug.
BUSINESS
December 13, 1994 | Jack Searles
George Rathmann, the founder of Amgen Inc., the Thousand Oaks biotechnology concern, has increased his ownership in another biotech firm, Bothell, Wash.-based Icos Corp. Rathmann, who is Icos' chairman, along with Microsoft Corp. founder William Gates bought about half the Icos shares available in a special offering last month. The two executives, who are among Icos' largest shareholders, acted independently. Rathmann raised his stake to about 7.8% from 6.5%.
BUSINESS
October 22, 1991 | BARRY STAVRO, TIMES STAFF WRITER
George Rathmann spent the 1980s nurturing tiny Thousand Oaks-based Amgen Inc. from a vague idea into the nation's most successful biotechnology company. His goal for the 1990s was simply to retire. So why is Rathmann, now 63, working as hard as ever trying to duplicate his Amgen triumph as chairman of Icos Corp., another infant biotechnology company? "There's an irrational element in this," Rathmann conceded about his retirement detour.
BUSINESS
October 22, 1991 | BARRY STAVRO, TIMES STAFF WRITER
George Rathmann spent the 1980s nurturing tiny Thousand Oaks-based Amgen Inc. from a vague idea into the nation's most successful biotechnology company. His goal for the 1990s was simply to retire. So why is Rathmann, now 63, working as hard as ever trying to duplicate his Amgen triumph as chairman of Icos Corp., another infant biotechnology company? "There's an irrational element in this," Rathmann conceded about his retirement detour.
BUSINESS
December 24, 2001 | From Associated Press
Here are the eight Eli Lilly & Co. drugs the company hopes to launch by the end of 2004, pending regulatory approval, with expected launch dates: * Forteo: A bone-building agent to reverse osteoporosis, 2002. * Cialis: Developed with Bothell, Wash.-based Icos Corp. to treat male erectile dysfunction, 2002. * Atomexetine: A non-stimulant to treat attention deficit disorder in children, late 2002. * Duloxetine: For depression, late 2002.
BUSINESS
October 22, 1991 | BARRY STAVRO, TIMES STAFF WRITER
George Rathmann spent the 1980s nurturing a tiny Thousand Oaks company named Amgen Inc. from a vague idea into the most successful biotechnology company yet developed. His goal for the 1990s was simpler: retire. So why is Rathmann, now 63, working as hard as ever at the helm of another infant biotechnology company called Icos Corp. in Bothell, Wash., and trying to duplicate his triumph at Amgen? "There's an irrational element in this," Rathmann conceded about his retirement detour.
Los Angeles Times Articles
|